Gene10331
B3GNT3: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
Cite this record
ConductScience Library. B3GNT3: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3. Genes, record 10331. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/10331
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y2A9 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 | 372 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents115
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260201011 A1 | 2026-07-16 | 1334 | Q9Y2A9 | Espacenet |
| US 20260201011 A1 | 2026-07-16 | 1335 | Q9Y2A9 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 5003 | Q9Y2A9 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 5564 | Q9Y2A9 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 1334 | Q9Y2A9 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 1335 | Q9Y2A9 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 1334 | Q9Y2A9 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 1335 | Q9Y2A9 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 69186 | Q9Y2A9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 5003 | Q9Y2A9 | Espacenet |
NIH grants216
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | B3GNT3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA036727 | Buffett Cancer Center Support Grant | 3 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| R35GM119850 | Unraveling the mammalian secretory pathway through systems biology and algorithm development | 2 | 2025 |
| F30OD031914 | MicroRNA-375 regulation of enteroendocrine cell biology in diet-induced obesity and bariatric surgery | 1 | 2025 |
| P30AG072946 | University of Kentucky Alzheimer's Disease Research Center | 1 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 1 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 1 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 1 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 1 | 2025 |
Source NIH's project files
Papers309
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B3GALT5 regulates renal A/B antigen levels: a determinant of prognosis and rejection in ABO-incompatible kidney transplantation. | J Glob Health | 2026 | 42788334 | PubTator, text mining | PubMed |
| Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. | Oncogene | 2026 | 42533113 | PubTator, text mining | PubMed |
| Oxymatrine Synergizes with 5-fluorouracil to Inhibit the Proliferation of A549 Cells by Targeting APE1. | Curr Med Chem | 2026 | 42522309 | PubTator, text mining | PubMed |
| Association of B3GNT3 Expression with Tumour Stage and Lymph Node Metastasis in Colon Adenocarcinoma. | Int J Mol Sci | 2026 | 42511615 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of Human Transcriptomic Data Identifies Three Key Diagnostic and Prognostic Biomarkers in Lung Adenocarcinoma. | J Vis Exp | 2026 | 42475443 | PubTator, text mining | PubMed |
| Evaluation of the impact of glycolysis-related gene signatures on prognosis and therapeutic targeting in lung adenocarcinoma. | Cytotechnology | 2026 | 41987806 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for lung adenocarcinoma based on necrotic cell death triggered by sodium overload-related coexpressed genes. | Front Genet | 2026 | 41847125 | PubTator, text mining | PubMed |
| B3GNT3 facilitates NFKB2 processing and non-canonical NF-κB activation to drive lung adenocarcinoma progression. | Cell Oncol (Dordr) | 2026 | 41838238 | PubTator, text mining | PubMed |
| Strategies to target PD-1/PD-L1 in the tumor microenvironment. | Cell Oncol (Dordr) | 2026 | 41784760 | PubTator, text mining | PubMed |
| Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease. | medRxiv | 2026 | 41757160 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10331
GET https://conductscience.org/api/genes/v1/10331/patents?page=2